Src
Catalog No. | Inhibitor Name | Src | Lck | Fyn | Lyn | Yes | Other |
---|---|---|---|---|---|---|---|
A10290 | Dasatinib | **** | Abl,c-Kit (D816V),c-Kit (wt) | ||||
A10108 | Saracatinib | *** | *** | ** | *** | EGFR (L861Q),c-YES,EGFR (L858R) | |
A10161 | Bosutinib | **** | Abl | ||||
A11177 | KX2-391 | ** | |||||
A10661 | NVP-BHG712 | * | EphB4,C-Raf,c-Abl | ||||
A12723 | PP2 | *** | *** | *** | EGFR | ||
A12724 | PP1 | *** | *** | ** | Kit,EGFR,Bcr-Abl | ||
A15518 | SU6656 | * | * | * | * | ||
A16320 | Dasatinib Monohydrate | **** | Abl ,c-Kit (D816V),c-Kit (wt) | ||||
A14117 | WH-4-023 | **** | **** | ||||
A10766 | Quercetin | Sirtuin,PKC,PI3Kγ | |||||
A11288 | A-770041 | * | |||||
A12417 | MLR 1023 | ** | |||||
A13232 | 1-NA-PP1 | **** | **** | c-Abl, CDK2, CAMK II | |||
A13415 | MCB-613 | *** | **** | **** | |||
A13819 | TG 100801 | **** | **** | VEGFR1, VEGFR2, FGFR1 | |||
A13820 | TG 100572 | **** | **** | VEGFR1, VEGFR2, FGFR1 | |||
A13868 | PD 166285 | FGFR1, PDGFRβ, Wee1 | |||||
A16241 | AZM475271 | **** |
Notes:
1.Hover mouse over " " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
-
T338C Src-IN-2
Catalog No. A16244 Src 抑制剂T338C Src-IN-2是有效的突变c-Src T338C激酶抑制剂,IC50为317 nM;它还抑制T338C/V323A和T338C/V323S,IC50为57 nM/19 nM。 了解更多 -
T338C Src-IN-1
Catalog No. A16243 Src 抑制剂T338C Src-IN-1是有效的Src T338C突变体抑制剂。相对于WT c-Src(增加10倍),T338C(IC50 = 111 nM)的抑制作用最强。 了解更多 -
AZM475271
Catalog No. A16241 -
KX2-391 2HCl
Catalog No. A11471 Src 抑制剂Tirbanibulin dihydrochloride是首个靶向Src肽底物位点的临床Src抑制剂(拟肽类),在癌细胞系中GI50为9-60 nM。 了解更多 -
TG 100572 HCl
Catalog No. A15260 VEGFR2/Src kinase 抑制剂TG 100572 HCl是一种多靶点激酶抑制剂,可抑制选择性生长因子受体酪氨酸激酶和Src家族激酶,分别对VEGFR1/VEGFR2/FGFR1/Src/Fyn kianse的IC50值为2/7/2/1/0.5 nM。 了解更多 -
Dasatinib hydrochloride
Catalog No. A15060 Src 抑制剂Dasatinib hydrochloride是一种有效的Abl/Src双重抑制剂,IC50分别<1 nM/0.8 nM。还可以抑制c-Kit(WT/c-Kit(D816V),IC50为79 nM/37 nM。有效,选择性Raf激酶抑制剂能够抑制野生型B-Raf,B-RafV600E和c -Raf的IC50值分别为3.2、0.8和5.0 nM。 了解更多 -
PD-166285
Catalog No. A13868 -
Saracatinib (AZD0530)
Catalog No. A10108 Src/Abl 抑制剂Saracatinib (AZD0530)是一种高选择性,双特异性Src/Abl激酶抑制剂,对c-Src和Abl激酶的IC50分别为2.7和30 nM。 了解更多 -
Bosutinib (SKI-606)
Catalog No. A10161 -
Dasatinib (BMS-354825)
Catalog No. A10290 Abl-Src 抑制剂Dasatinib (BMS-354825)是一种口服多BCR/ABL和Src家族酪氨酸激酶抑制剂。Dasatinib (BMS-354825)的主要靶标是BCR/ABL,Src,c-Kit,ephrin受体和其他几种酪氨酸激酶,但不是erbB激酶,例如EGFR或Her2。 了解更多 -
NVP-BHG712
Catalog No. A10661 EphB4 抑制剂NVP-BHG712是EphB4激酶的选择性抑制剂,在体外对EphB4的选择性超过40多种其他激酶(包括FGFR3)。 了解更多 -
KIN001-051
Catalog No. A16923 Lck 抑制剂KIN001-051是一种有效的、选择性的Lck抑制剂。淋巴细胞特异性蛋白酪氨酸激酶(Lck)是非受体蛋白酪氨酸激酶Src家族的成员,在触发细胞因子产生的T细胞受体信号转导的初始步骤中起着至关重要的作用。 了解更多 -
Lyn-IN-1
Catalog No. A16265 -
Tilfrinib
Catalog No. A16086 -
Quercetin (Sophoretin)
Catalog No. A10766 MAO-B 抑制剂Quercetin (Sophoretin)抑制许多酶系统,包括酪氨酸蛋白激酶,磷脂酶A2,磷酸二酯酶,线粒体ATPase,PI 3-激酶和蛋白激酶C。 了解更多 -
Lck inhibitor 2
Catalog No. A15141 Lck 抑制剂Lck inhibitor 2 是酪氨酸激酶的双苯胺基嘧啶抑制剂,包括LCK,BTK,LYN,SYK和TXK。Lck,Btk,Lyn,Btk和Txk的IC50值分别为13nM,9nM,3nM,26nM和2nM。 了解更多 -
TC-S 7003 (Lck Inhibitor)
Catalog No. A15140 -
1-NA-PP1
Catalog No. A13232 -
PP1 Analog II, 1NM-PP1
Catalog No. A13573 PP1 Analog II, 1NM-PP1是一种细胞可渗透的PP1类似物,对突变激酶的野生型祖细胞起有效和选择性的抑制作用。 了解更多 -
TG 100801
Catalog No. A13819 -
CGP77675
Catalog No. A13821